We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Secukinumab‐induced subacute cutaneous lupus erythematosus.
- Authors
Conforti, Claudio; Retrosi, Chiara; Giuffrida, Roberta; Vezzoni, Roberta; Currado, Damiano; Navarini, Luca; Farinazzo, Eleonora; Dell'Aquila, Carmen; Nan, Katiuscia; Di Meo, Nicola; Zalaudek, Iris
- Abstract
Drug-induced lupus erythematosus (DILE) is a well-known entity first described as an adverse effect of hydrochlorothiazide, terbinafine, and TNF-alfa inhibitors. Histological examination showed perivascular infiltrate of lymphocytes, parabasal vacuolization, normal granular layer and necrotic keratinocytes (Figure 1D), features suggestive of subacute cutaneous lupus. 4 Goh SW, Jamil A, Nor NM, Cader RA, Shaharir SS. Exacerbation of systemic lupus erythematosus in a patient with concomitant chronic plaque psoriasis treated with ustekinumab.
- Subjects
LUPUS erythematosus; PATHOLOGY; DRUG side effects; T cell differentiation; ERYTHEMA multiforme
- Publication
Dermatologic Therapy, 2020, Vol 33, Issue 3, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.13417